Aesthetic Brokers, a sell-side M&A advisory firm for medical aesthetics practices, has published the Q3 2026 edition of The Aesthetic Brief, a quarterly market report finding that buyers now weigh key-person risk and earnout structure as heavily as growth when they evaluate an acquisition.
The report, released Oct. 8, 2026, includes a founder's note from Bill Walker, the firm's founder and chief executive officer, and a column by Jessica Hunter, head of aesthetic consulting. It describes a healthcare deal market that remains active but more selective, citing the KPMG H1 2026 Healthcare M&A report, which found that healthcare deal volume fell 12.6% year over year in the first half of 2026. According to The Aesthetic Brief, buyers are favoring strategic fit, operational efficiency and long-term sustainability over scale alone.
The report identifies key-person risk as the question buyers now raise first. When a large share of a practice's revenue depends on a single clinician, such as a top injector, buyers increasingly walk away or restructure the offer, and staffing depth and clinical continuity now receive the same scrutiny in diligence as the financial statements. The report recommends that founders run a stress test modeling lower average tickets and slower high-ticket sales, and it notes that memberships and recurring maintenance visits have proved more resilient than one-time purchases.
"Buyers are underwriting the whole team now, not only the founder," said Bill Walker, founder and chief executive officer of Aesthetic Brokers. "Practices that document clinical depth and recurring revenue well before a sale keep more leverage once earnout terms reach the table."
The report also tracks a reversal in how earnouts function. Between 2020 and 2024, according to The Aesthetic Brief, earnouts mainly gave sellers a way to capture additional upside after closing. In current transactions, the report finds, they mainly protect buyers if revenue underperforms, while buyers underwrite growth more conservatively. The firm notes that the widening gap between average and premium practices shows up directly in the valuation multiple a seller is offered.
On the demand side, the report cites procedural statistics for 2025 released in September by the American Society of Plastic Surgeons, which showed cosmetic surgical procedure volume rising 7% year over year, with facelifts up 13% and neck and arm lifts each up 21%. The report treats those figures as context for buyer interest rather than as a forecast for any individual practice. The edition is the third quarterly report the firm has published in 2026, following a Q1 edition in April and a Q2 edition in July.
Hunter's column, titled "The Missed Opportunity in Your Operational Platform," argues that patient data already stored in a practice's operating software can be used to improve rebooking and revenue per patient, two measures buyers examine closely in diligence. Her recommendation is that owners work with the patients already on the books before spending on new patient acquisition.
Aesthetic Brokers represents practice owners on the sell side and reports in the Q3 edition a track record spanning three years, 11 states and four platforms created. Walker previously worked in private-equity-backed healthcare M&A and served as a Marine Corps pilot. The firm's team also includes Drew Smyth, vice president of mergers and acquisitions. The firm works with owners across eight practice categories, including medical spas, cosmetic dermatology, plastic surgery, ambulatory infusion, women's health and cosmetic and specialty dentistry.
The full Q3 2026 edition of The Aesthetic Brief is posted in the Industry Trends section of the firm's blog alongside the Q1 and Q2 editions. Office location and contact details are listed on the Google Business Profile for Aesthetic Brokers.
This information is general market commentary and does not constitute legal, tax, accounting or investment advice. Information is believed accurate at the time of publication. Contact Aesthetic Brokers directly for current details.
About Aesthetic Brokers
Aesthetic Brokers is a sell-side M&A advisory firm for medical aesthetics and cash-pay medical practices in the United States. Founded by Bill Walker, a former private-equity healthcare M&A professional, the firm provides transaction advisory, valuation and due diligence support and publishes The Aesthetic Brief, a quarterly market report. Aesthetic Brokers is located at 800 Silverado St #301A, La Jolla, CA 92037, and can be reached at (619) 742-0310 or aestheticbrokers.com.
###
For more information about Aesthetic Brokers, contact the company here:
Aesthetic Brokers
Bill Walker
16197420310
bill@aestheticbrokers.com
800 Silverado St #301A, La Jolla, CA 92037, United States